Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 931-472-4 | CAS number: 182700-89-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 6 February to 12 March 1995
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 995
- Report date:
- 1995
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- The study was conducted prior to the development and use of the LLNA protocol
Test material
- Reference substance name:
- Benzoic acid, 2-hydroxy-,C14-18 alkyl derivs.
- EC Number:
- 931-472-4
- Cas Number:
- 182700-89-6
- IUPAC Name:
- Benzoic acid, 2-hydroxy-,C14-18 alkyl derivs.
- Reference substance name:
- 605-976-7
- EC Number:
- 605-976-7
- IUPAC Name:
- 605-976-7
- Test material form:
- liquid: viscous
- Details on test material:
- - Physical state: opaque, pale brown viscous liquid
- Stability under test conditions: not given, the responsibility of the sponsor
- Storage condition of test material: ambient temperature, protected from light, under nitrogen in a flameproof cabinet
- Other: flash point >32 °C; density at 20 °C 0.92 kg/L; viscosity at 20 °C 5 mm²/s
Constituent 1
Constituent 2
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 6 to 8 weeks
- Weight at study initiation: control animals 323 to 396 g, test animals 317 to 412 g on day 1
- Housing: no more than 5 animals/sex/cage in suspended stainless steel cages with grid floors and tops
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: at least 6 days but not more than 16 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 to 23
- Humidity (%): 37 to 66
- Air changes (per hr): at least 10; without recirculation
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- propylene glycol
- Concentration / amount:
- First (intradermal) induction: 5 % v/v in propylene glycol or 5 % v/v in propylene glycol in FCA
Second (topical) induction: 10 % v/v in propylene glycol
Topical challenge: 1 or 5 % v/v in propylene glycol
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- propylene glycol
- Concentration / amount:
- First (intradermal) induction: 5 % v/v in propylene glycol or 5 % v/v in propylene glycol in FCA
Second (topical) induction: 10 % v/v in propylene glycol
Topical challenge: 1 or 5 % v/v in propylene glycol
- No. of animals per dose:
- Test group: 10 animals/sex, control group: 5 animals/sex
- Details on study design:
- RANGE FINDING TESTS: Intradermal and topical range finding studies were conducted. Four guinea-pigs received 6 intradermal injections of 0.1 mL of 3 concentrations of the test material in propylene glycol and three concentrations of the test material in propylene glycol and an emulsion of FCA into the skin overlying the scapulae. Two guinea-pigs received the maximum practicable concentration in each medium and two dilutions (10, 30 or 50 % v/v). The other two animals received three lower concentrations in each medium (1, 3 or 5 % v/v). Reactions to treatment were assessed approx. 24 and 48 h and 7 days after injection. For the topical induction range finding test, two guinea-pigs were subjected to a single intradermal injection of 0.1 mL FCA at least 5 days before topical application. The hair was removed from both flanks of the animals and topical application of 0.25 mL of the maximum practicable concentration of the test material and three lower concentrations in propylene glycol (10, 30, 50 % or as supplied) was administered to the four test sites on each guinea-pig, on a 2 x 2 cm absorbent patch which was covered by an occlusive dressing for 48 h. Reactions were assessed approx. 24 and 48 hr and 7 days after removal of the dressings. For the topical challenge range finding test, 3 guinea-pigs received a single intradermal injection of 0.1 mL FCA at least 20 days before topical application. The hair was removed from both flanks of the animals and topical application of 0.03 mL of 4 concentrations of the test material in propylene glycol (1, 3, 5 or 10 % v/v) was administered to the four test sites on each animal, applied on a 1 cm diameter absorbent patch which was covered by an occlusive dressing for 24 h. Reactions were assessed approx. 24 and 48 h after removal of the dressings.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2
- Exposure period: about 10 days
- Test groups: test material in propylene glycol or propylene glycol and FCA for the injection phase, test material in propylene glycol for the topical phase
- Control group: FCA, propylene glycol or propylene glycol in FCA
- Site: intradermal injections on the dorsal surface, parallel to the spinal column and near to the periphery of the dermal induction site overlying the scapulae
- Frequency of applications: one intradermal injection exposure on day 1 and one topical exposure on day 8
- Duration: 10 days (total); 2 days (topical)
- Concentrations: intradermal injection of 5 % v/v test material, topical application of 10 % v/v test material.
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day of challenge: 22
- Exposure period: 24 h
- Test groups: test substance in propylene glycol or propylene glycol alone
- Control group: test substance in propylene glycol or propylene glycol alone
- Site: right flank for test substance, left flank for vehicle
- Concentrations: 1 and 5 % v/v
- Evaluation (hr after challenge): 24 and 48 h after removal of the occlusive dressings
OTHER: test sites were wiped with a paper tissue moistened with propylene glycol immediately after the removal of the bandage. Significant erythematous reactions were considered as Grade 1 or above and barely perceptible erythema (grade ±) was not considered to be a significant or conclusive indication of delayed contact hypersensitivity. - Challenge controls:
- See Details on study design (above)
- Positive control substance(s):
- no
Results and discussion
- Positive control results:
- this OECD guideline does not involve a positive control substance, merely the use of FCA as a potentiator/exacerbator of the reaction
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- other: M&K test does not use positive control
- Hours after challenge:
- 0
- Group:
- positive control
- Dose level:
- N/A
- No. with + reactions:
- 0
- Total no. in group:
- 0
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 5%
- No. with + reactions:
- 7
- Total no. in group:
- 20
- Clinical observations:
- Severe erythema with eschar formation in 2, slight erythema in 5
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 5%
- No. with + reactions:
- 10
- Total no. in group:
- 20
- Clinical observations:
- Severe erythema and eschar formation in 2 with one also showing exfoliation, slight erythema in 8 with 6 showing exfoliation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 5%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 1%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 1%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 0% (vehicle control)
- No. with + reactions:
- 0
- Total no. in group:
- 20
Any other information on results incl. tables
At induction, intradermal injection of the test material at 5 % in propylene glycol caused slight erythema in all animals and pallor in nearly half the males, while 5 % in propylene glycol with FCA caused moderate erythema in all animals and pallor in 8/20 animals. Intradermal injection of FCA alone caused moderate erythema in all guinea-pigs tested. Topical application of 10 % in propylene glycol caused exfoliation in all animals and occasional eschar formation while propylene glycol alone caused no dermal reaction. Throughout the experimental period, the animals remained in overt good health and achieved anticipated overall bodyweight gains.
Overall, 11 (55 %) of the 20 test group guinea pigs (6 males and 5 females) gave a dermal response of grade 1 or more when assessed 24 and 48 h after removal of the challenge dose.
Applicant's summary and conclusion
- Interpretation of results:
- Category 1 (skin sensitising) based on GHS criteria
- Conclusions:
- The test material caused delayed contact hypersensitivity in the guinea-pig Maximisation test.
- Executive summary:
In a GLP study conducted according to OECD Guideline 406 and EU Method B.6, ten male and ten female Dunken-Hartley guinea pigs were induced, in a Magnusson and Kligman maximisation test, with an intradermal injection of 5 % test material (approximately 65 % active substance, 35 % xylene) in propylene glycol (with or without Freunds Complete Adjuvant (FCA)), followed seven days later by a 48-h occlusive dermal application of 10 % test material in proplyene glycol to the closely clipped dorsa. Five male and five female animals served as the controls and were treated with FCA alone, propylene glycol alone, or FCA and propylene glycol together. All animals were challenged, on day 22, with a 24-h occluded application of propylene glycol, or 1 or 5 % test material in propylene glycol. These test sites were assessed 24 and 48 h after removal of the dressing.
Challenge application of 5 % test material in propylene glycol gave rise to a significant dermal response (slight erythema or a more marked reaction) in seven and ten of the 20 animals assessed 24 and 48 h after removal of the challenge patch, respectively. Overall, eleven test (55 %) and none of the control animals responded positively to challenge, whereas challenge with the 1 % concentration, or propylene glycol alone, caused no significant response. It is concluded that, under the conditions of this study, repeated administration of the test material caused delayed contact hypersensitivity in guinea pigs.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.